Skip to content

Author

Priyanka

We have 4 of 31 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

MRI-based machine learning models for differentiating Parkinson’s disease and Progressive Supranuclear Palsy

Background Parkinson’s disease (PD) and Progressive Supranuclear Palsy (PSP) are neurodegenerative disorder which have Parkinsonism as core clinical feature. PD and PSP are often misdiagnosed in early phases by conventional magnetic resonance imaging (MRI). Hence the objective of the study is to evaluate accuracy of MR...

Vilhoubeinuo Veronica Khruomo, Priyanka, R. Kadavigere et al. · 0 citations
Review Open access Aug 2026

Longitudinal changes in brain iron quantification biomarkers and their association with clinical severity in parkinson’s disease: a systematic review

Reliable biomarkers for tracking Parkinson’s disease (PD) progression remain an unmet clinical need. Quantitative susceptibility mapping (QSM), an MRI technique sensitive to iron-related susceptibility changes, has emerged as a promising candidate biomarker; however, longitudinal findings have been limited and in...

Thejas M. S., S. Pendem, Arvind N. Prabhu et al. · 0 citations
Review Open access Oct 2026

Multimodal MRI markers of white matter hyperintensities and their impact on cognition in cerebral small vessel disease: a systematic review

It is suggested that WMH burden and disrupted white matter microstructure are associated with cognitive impairment in CSVD, and larger, standardized studies are needed to determine the clinical value of MRI markers as reliable biomarkers for early detection and monitoring of cognitive impairment in CSVD.

Babina Aryal, S. Pendem, Priya P. S. et al. · 0 citations
Aug 2026

Evaluation of acquisition strategies in IVIM-DKI brain imaging: Effects on image quality, parameter stability, and comparison with DSC perfusion.

An optimized low b-value-weighted acquisition with targeted averaging (A2) provided the strongest overall balance between image quality, parameter stability, tissue contrast, and correspondence with DSC-derived perfusion measures.

A. S., S. Pendem, R. Kadavigere et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.